Question 1

What is Innovent Biologics?

Accepted Answer

Innovent Biologics is a Company.

Question 2

How often does Innovent Biologics appear in global news?

Accepted Answer

Tracked across 7 news events drawn from 48 articles.

Question 3

When was Innovent Biologics first tracked by Ergen?

Accepted Answer

First tracked on May 08, 2026.

Question 4

When was Innovent Biologics last mentioned in news?

Accepted Answer

Last active on Aug 14, 2026.

Question 5

What is Innovent Biologics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 24 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Innovent Biologics in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 7 events.

Question 7

What is the most recent event involving Innovent Biologics?

Accepted Answer

IBI363 Shows Survival Benefits in NSCLC (May 21, 2026, 9 articles).

Question 8

How did the "IBI363 Shows Survival Benefits in NSCLC" event impact Innovent Biologics?

Accepted Answer

Innovent Biologics is the developer and co-commercializer of IBI363, and the positive long-term clinical trial results enhance its product pipeline and market position in oncology. The company's stock performance is likely to benefit from these favorable outcomes and the progression to global Phase 3 studies.

Question 9

How did the "Spero $105M royalty financing" event impact Innovent Biologics?

Accepted Answer

Innovent licensed SP001 to Spero, enabling Spero's immunology pipeline.

Question 10

How did the "OPKO Health issues $125M notes to HealthCare Royalty" event impact Innovent Biologics?

Accepted Answer

Innovent Biologics commercializes mazdutide in China, driving the royalty stream that underpins the financing. Its performance directly affects the value of the royalty interests.

Question 11

How did the "IASO Bio acquires MediSix Therapeutics" event impact Innovent Biologics?

Accepted Answer

Collaborator of IASO Bio; unaffected directly.

Question 12

How did the "Beyang Therapeutics closes $30M Series A" event impact Innovent Biologics?

Accepted Answer

Innovent Biologics is mentioned as a portfolio company of Legend Holdings, indicating the investor's expertise but not directly impacted.

Question 13

How did the "Dajun Yang named to Power List" event impact Innovent Biologics?

Accepted Answer

Innovent is a partner of Ascentage Pharma, but this event does not directly involve Innovent.

Question 14

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.